INT282863

From wiki-pain
Jump to: navigation, search
Context Info
Confidence 0.01
First Reported 2009
Last Reported 2009
Negated 0
Speculated 0
Reported most in Body
Documents 1
Total Number 1
Disease Relevance 1.07
Pain Relevance 0.19

This is a graph with borders and nodes. Maybe there is an Imagemap used so the nodes may be linking to some Pages.

extracellular region (Bpifa2, Aggf1) cell differentiation (Aggf1) lipid binding (Bpifa2)
cell adhesion (Aggf1) intracellular (Aggf1) cytoplasm (Aggf1)
Anatomy Link Frequency
PSP 2
Bpifa2 (Mus musculus)
Aggf1 (Mus musculus)
Pain Link Frequency Relevance Heat
Inflammation 19 97.04 Very High Very High Very High
Inflammatory response 1 48.64 Quite Low
metalloproteinase 5 5.00 Very Low Very Low Very Low
cytokine 2 5.00 Very Low Very Low Very Low
chemokine 2 5.00 Very Low Very Low Very Low
ketamine 1 5.00 Very Low Very Low Very Low
anesthesia 1 5.00 Very Low Very Low Very Low
Disease Link Frequency Relevance Heat
Corneal Neovascularization 39 100.00 Very High Very High Very High
INFLAMMATION 20 97.04 Very High Very High Very High
Burns 10 79.16 Quite High
Eye Disease 1 61.16 Quite High
Disease 3 47.12 Quite Low
Corneal Disease 3 35.52 Quite Low
Pathologic Neovascularization 1 34.72 Quite Low
Wound Healing 4 5.00 Very Low Very Low Very Low
Cancer 3 5.00 Very Low Very Low Very Low
Necrosis 2 5.00 Very Low Very Low Very Low

Sentences Mentioned In

Key: Protein Mutation Event Anatomy Negation Speculation Pain term Disease term
As shown in Figure 5, PSP suppressed the expression of VEGF, MMP2, and MMP9 and stimulated the expression of PEDF, suggesting that PSP may inhibit CNV by downregulating the expression of angiogenic factors and upregulating the expression of the anti-angiogenic factor.
PSP Positive_regulation (upregulating) of Gene_expression (expression) of anti-angiogenic factor in PSP associated with corneal neovascularization
1) Confidence 0.01 Published 2009 Journal Molecular Vision Section Body Doc Link PMC2751803 Disease Relevance 1.07 Pain Relevance 0.19

General Comments

This test has worked.

Personal tools
Namespaces

Variants
Actions
Navigation
Toolbox